WHO Technical Report Series, No. 981 - World Health Organization
WHO Technical Report Series, No. 981 - World Health Organization
WHO Technical Report Series, No. 981 - World Health Organization
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>WHO</strong> Expert Committee on Specifications for Pharmaceutical Preparations<br />
Ms M.-L. Rabouhans, Chiswick, London, England<br />
Dr J.-L. Robert, Head of Department, Service du Contrôle des Médicaments, Laboratoire<br />
National de Santé, Luxembourg<br />
Dr A.J. van Zyl, Sea Point, South Africa<br />
Representation from United Nations offices 2<br />
United Nations Children's Fund (UNICEF)<br />
Dr P.S. Jakobsen, Quality Assurance Specialist, UNICEF Supply Division, Copenhagen,<br />
Denmark<br />
Representation from specialized agencies and related organizations 3<br />
The Global Fund to Fight AIDS, Tuberculosis and Malaria<br />
Ms J. Daviaud, Quality Assurance Specialist, Grant Management Support, Geneva,<br />
Switzerland<br />
Representation from intergovernmental organizations 4<br />
Council of Europe<br />
Dr A. Lodi, Head of Laboratory Department, European Directorate for the Quality of<br />
Medicines & <strong>Health</strong>Care, Strasbourg, France<br />
Representation from nongovernmental organizations 5<br />
International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)<br />
Dr G.L. France, Vice Chair, Regulatory Policy and <strong>Technical</strong> Standards (RPTS), IFPMA, and<br />
Region Head, Quality Europe, <strong>No</strong>vartis Consumer <strong>Health</strong> Services SA, <strong>No</strong>vartis Group:<br />
Quality Systems & Standards, Switzerland<br />
Dr R. Horder, Abbott, England.<br />
International Generic Pharmaceutical Alliance (IGPA)<br />
Dr N. Cappuccino, Chief Executive Officer, Pharmaceutical Intellectual Resource Services<br />
LLC, Lambertville, NJ, USA<br />
2<br />
Unable to attend: United Nations Development Programme, New York, NY, USA.<br />
3<br />
Unable to attend: International Atomic Energy Agency, Vienna, Austria; United Nations Industrial<br />
Development <strong>Organization</strong>, Vienna, Austria; <strong>World</strong> Intellectual Property <strong>Organization</strong>, Geneva, Switzerland;<br />
The <strong>World</strong> Bank, Washington, DC, USA; <strong>World</strong> Customs <strong>Organization</strong>, Brussels, Belgium; <strong>World</strong> Trade<br />
<strong>Organization</strong>, Geneva, Switzerland.<br />
4<br />
Unable to attend: European Commission, Brussels, Belgium; European Medicines Agency, London,<br />
England.<br />
5<br />
Unable to attend: Commonwealth Pharmacists Association, London, England; European Chemical Industry<br />
Council, Brussels, Belgium.<br />
vii
Change language